Telmisartan and Hydrochlorothiazide (Alembic Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Telmisartan and Hydrochlorothiazide drug offered from Alembic Pharmaceuticals Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alembic Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Telmisartan and Hydrochlorothiazide |
| SUBSTANCE NAME: | TELMISARTAN; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-06-25 |
| END MARKETING DATE: | 0000-00-00 |
Telmisartan and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Telmisartan and Hydrochlorothiazide from Alembic Pharmaceuticals Inc. |
| LABELER NAME: | Alembic Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2016-06-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62332-209_e80f232c-c1c4-4524-a0a5-d23ee0d1f3b7 |
| PRODUCT NDC: | 62332-209 |
| APPLICATION NUMBER: | ANDA203010 |
Other TELMISARTAN; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
